Drug Trial Radar · NCT07575932
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
940
Actual
Start
May 11, 2026
Primary completion
Aug 4, 2027
Study completion Jan 5, 2028
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Conditions
- Overweight
- Obesity
- Overweight and/or Obesity
- Overweight or Obesity
- Overnutrition
- Nutrition Disorders
- Nutritional and Metabolic Diseases
- Body Weight
Interventions
PF-08653945Drug
Subcutaneous Injection
PF-08653944Drug
Subcutaneous Injection
PlaceboDrug
Subcutaneous Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in body weightTime frame: Baseline (Week 0) to Week 48
Locations
63 sites in 2 countries. Site status is shown where the registry gives one.
Clinical Research Institute of Arizona
Sun City West, Arizona
San Fernando Valley Health Institute
Canoga Park, California
Ark Clinical Research
Fountain Valley, California
Paragon Rx Clinical
Garden Grove, California
Torrance Clinical Research Institute, Inc.
Lomita, California
Ark Clinical Research
Long Beach, California
Collaborative Neuroscience Research, LLC
Los Alamitos, California
Paradigm Clinical Research-Modesto
Modesto, California
Paradigm Clinical Research Centers, LLC
San Diego, California
University Clinical Investigators, Incorporated
Tustin, California
Diablo Clinical Research, LLC dba Flourish Research
Walnut Creek, California
AGA Clinical Trials
Hialeah, Florida
Westside Center for Clinical Research
Jacksonville, Florida
New Horizon Research Center
Miami, Florida
Charter Research
Orlando, Florida
Atlanta Diabetes Associates
Atlanta, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Koch Family Medicine Clinical Research/Elite Research Network
Morton, Illinois
Bioluminux Clinical Research Illinois
Naperville, Illinois
Johnson County Clinical Trials
Lenexa, Kansas
DelRicht Research
Mandeville, Louisiana
DelRicht Research
Prairieville, Louisiana
Patient First Clinical Trials (PFCTRIALS)
Lutherville, Maryland
DelRicht Research
Springfield, Missouri
Mercury Street Medical Group, PLLC
Butte, Montana
Alliance Clinical Research Las Vegas (Excel Clinical Research)
Las Vegas, Nevada
AB Clinical Trials
Las Vegas, Nevada
Palm Research Center
Las Vegas, Nevada
Bioluminux Clinical Research
Hamilton, New Jersey
DelRicht Research
Charlotte, North Carolina
Monroe Biomedical Research
Monroe, North Carolina
Piedmont Healthcare
Statesville, North Carolina
Accellacare - Wilmington
Wilmington, North Carolina
Tekton Research, LLC.
Oklahoma City, Oklahoma
Preferred Primary Care Physicians
Pittsburgh, Pennsylvania
Preferred Primary Care Physicians, Inc.
Uniontown, Pennsylvania
Preferred Primary Care Physicians
Uniontown, Pennsylvania
TMA Headlands LLC (d/b/a Trial Management Associates)
Myrtle Beach, South Carolina
DelRicht Research
Hendersonville, Tennessee
Cedar Health Research - Euless
Euless, Texas
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.